Allergan proxy war gets ugly as Valeant aims to unseat the board

Activist investor Bill Ackman teams up with Valeant Pharmaceuticals to push out members of Allergan's board in an increasingly hostile attempt to acquire the Botox-maker. After sweetening the pot last week, activist investor Valeant Pharmaceuticals is taking a more aggressive approach in its unsolicited (and unrequited) attempt to buy Botox-maker Allergan (NYSE:AGN). Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.News Well, Cosmetic/Aesthetic, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beatread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news